课题基金 / 基金详情

项目摘要

项目成果

David M Allman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Age-related defects in hematopoietic stem cell (HSC) function may hamper the application of HSC-based therapies for elderly individuals. We have undertaken a series of studies investigating HSC function in aged mice. With this model system, we have determined that aging leads to markedly inefficient generation of early B lymphocyte progenitor cells from HSCs. We propose to further explore the cellular and molecular basis for this defect via four specific aims. In Aim 1, we will determine when early B-lineage precursors first decline with age and define the earliest stage in B-lineage differentiation affected by the aging process. In Aim 2, we will test whether age-associated loss of early lymphoid progenitors is due to cell intrinsic defects in HSCs, and test whether noncanonical lymphoid progenitors contribute to the B cell lineage in the elderly. In Aim 3, we will elucidate the impact of HSC aging on the capacity of early B cell precursors to respond to the cytokine IL-7 and sustain B-lineage differentiation. Finally, in Aim 4, we will define the role of the E2a and EBF transcription factors in the age-associated loss of very early B-lineage progenitors. Together, these studies will enhance our knowledge of stem cell biology and the basis for age-related defects in early lymphocyte development.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Biochemical Mechanisms for Sustained Humoral Immunity
  • 批准号:
    10637251
  • 项目类别:
  • 资助金额:
    $64.81万
  • 财政年份:
    2023
  • 负责人:
    David M Allman
  • 依托单位:
The Notch Pathway in Antigen Design
  • 批准号:
    10575892
  • 项目类别:
  • 资助金额:
    $26.4万
  • 财政年份:
    2023
  • 负责人:
    David M Allman
  • 依托单位:
Plasma Cell Regulation by Purinergic Receptors
  • 批准号:
    10441466
  • 项目类别:
  • 资助金额:
    $20.31万
  • 财政年份:
    2021
  • 负责人:
    David M Allman
  • 依托单位:
Plasma Cell Regulation by Purinergic Receptors
  • 批准号:
    10240081
  • 项目类别:
  • 资助金额:
    $24.38万
  • 财政年份:
    2021
  • 负责人:
    David M Allman
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: